Health Canada approves Spartan Cube COVID-19 test. - Spartan Bioscience
Related news and insights
Trevena, Inc. announced that TRV 027, the Company’s novel AT1 receptor selective agonist, has been selected for inclusion in an international, multi-site, adaptive, Phase II-Phase III trial in COVID-19 patients .
Rigel Pharmaceuticals, Inc announced positive topline results from a multi-center, Phase II clinical trial to evaluate the safety of fostamatinib, its oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of hospitalized patients with COVID-19.
Sorrento Therapeutics, Inc.announced updated positive results from its Phase 1b study of human allogeneic adipose-derived mesenchymal stem cells (COVI-MSC) for patients suffering from COVID-19-induced acute respiratory distress (ARD) or acute respiratory distress syndrome (ARDS).